Episode Details

Back to Episodes
Pharmaceutical Executive Daily: Novartis Shareholders Raise Concerns over M&A Strategy

Pharmaceutical Executive Daily: Novartis Shareholders Raise Concerns over M&A Strategy

Published 2 months, 1 week ago
Description
Novartis investors intensify pressure on the company's M&A strategy after a string of trial failures, Michelle Carnahan argues health care needs an orchestration layer rather than more point solutions, and Nacho Quinones and Aisling O'Loughlin make the case for synthetic advisory boards in biopharma decision-making.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us